{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:49:23Z","timestamp":1791668963133,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K10345"],"award-info":[{"award-number":["26K10345"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23KK0300"],"award-info":[{"award-number":["23KK0300"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijcard.2026.134760","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:27:16Z","timestamp":1788305236000},"page":"134760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intrarenal venous flow improvement after vericiguat in worsening HFrEF: indirect effect from improvements in cardiac hemodynamics or possible pleiotropic effect?"],"prefix":"10.1016","volume":"464","author":[{"given":"Hideaki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134760_bb0005","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134760_bb0010","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(25)01665-4","article-title":"Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial","volume":"406","author":"Butler","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134760_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.792798","article-title":"Cyclic GMP and PKG signaling in heart failure","volume":"13","author":"Numata","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijcard.2026.134760_bb0020","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/ehf2.15186","article-title":"Vericiguat improves cardiac remodelling and function in rats with doxorubicin-induced cardiomyopathy","volume":"12","author":"Chen","year":"2025","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134760_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ehf2.14802","article-title":"Evaluating haemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction","volume":"11","author":"Suzuki","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134760_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FJC.0000000000001761","article-title":"Effect of vericiguat on pulmonary artery pressures in patients with heart failure: real-world insights from pressure sensor monitoring","volume":"87","author":"Elad","year":"2026","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2026.134760_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13040856","article-title":"Different effects of riociguat and vericiguat on pulmonary vessels and airways","volume":"13","author":"Nubbemeyer","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijcard.2026.134760_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102589","article-title":"Early reduction of pulmonary artery pressures is associated with improved mortality among Medicare beneficiaries with heart failure","volume":"13","author":"Zalawadiya","year":"2025","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134760_bb0045","doi-asserted-by":"crossref","unstructured":"A. Gigante, G. Cusumano, A. D'Amato, et al, Intrarenal venous flow improvement after vericiguat in worsening HFrEF: a prospective VExUS-based study, Int. J. Cardiol. in press. doi: https:\/\/doi.org\/10.1016\/j.ijcard.2026.134682.","DOI":"10.1016\/j.ijcard.2026.134682"},{"key":"10.1016\/j.ijcard.2026.134760_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2014.12.014","article-title":"Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence","volume":"21","author":"Stasch","year":"2015","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326006108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326006108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:17:51Z","timestamp":1791667071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326006108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"alternative-id":["S0167527326006108"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134760","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrarenal venous flow improvement after vericiguat in worsening HFrEF: indirect effect from improvements in cardiac hemodynamics or possible pleiotropic effect?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134682","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134760"}}